Met Life Investment Management, LLC Vir Biotechnology, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 55,493 shares of VIR stock, worth $371,803. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,493
Previous 50,735
9.38%
Holding current value
$371,803
Previous $380,000
7.11%
% of portfolio
0.0%
Previous 0.0%
Shares
38 transactions
Others Institutions Holding VIR
# of Institutions
232Shares Held
90MCall Options Held
1.28MPut Options Held
235K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$112 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$110 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$88 Million0.0% of portfolio
-
State Street Corp Boston, MA5.07MShares$34 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$21.6 Million0.64% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $889M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...